Human characteristic mechanism of enzyme induction and the prediction
Human characteristic mechanism of enzyme induction and the prediction
批准号:
13470510
负责人:
YAMAZOE Yasushi
金额:
$9.15万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002
中文摘要
作为一种评估人CYP3A4诱导的工具,我们已经成功地制备了包括CYP3A4启动子和增强子区域的腺病毒载体系统。利用该载体在HepG2细胞中获得稳定活性的克隆。在选择的克隆中,对克隆响应于典型的化学诱导,并显示高荧光素酶报告活性。这些克隆被认为是候选人作为有效的工具,定量预测诱导潜力的人CYP3A4。我们目前正在评估克隆的实用工具。
英文摘要
As an estimation tool for human CYP3A4 induction, we have succeeded to make an adenovirus vecter system including CYP3A4 promoter and enhancer regions. The vecter was used to obtain the stably active clones in HepG2 cells. Among the clones selected, couple clones responded to typical chemical induces and showed high luciferase reporter activities. These clones are found to be candidates as effective tools for the quantitative prediction of inducing potential for human CYP3A4. We are currently evaluating the clones for the practical tools.
期刊论文(26)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
M.Furukawa: "Adenovirus vector-mediated reporter system for in vivo analysis of the human CYP3A4 gene activation"J. Biochem.. 131. 71-78 (2002)
M.Furukawa:“腺病毒载体介导的报告系统用于体内分析人CYP3A4基因激活”J。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
M.Shimada: "A hydroxysteroid sulfotransferase, St2b2, in a skin cholesterol sulfotransferase in mice"J. Biochem.. 131. 167-169 (2002)
M.Shimada:“小鼠皮肤胆固醇磺基转移酶中的羟基类固醇磺基转移酶 St2b2”J.
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
S.Matsumoto: "Involvement of CYP2J2 on the intestinal first-pass metabolism of antihistamine drug, astemizole"Drug Metab. Dispos.. 30. 1240-1245 (2002)
S.Matsumoto:“CYP2J2 参与抗组胺药物阿司咪唑的肠道首过代谢”Drug Metab。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
M.Ogino: "Selective suppression of human CYP3A form, CYP3A7, by troglitazone in HepG2 cells"Drug Metab. Pharmacokin.. 17. 42-46 (2002)
M.Ogino:“曲格列酮在 HepG2 细胞中选择性抑制人 CYP3A 形式 CYP3A7”Drug Metab。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
M.Ogino: "Selective suppressions of human CYP3A forms, CYP3A5 and CYP3A7, by troglitazone in HepG2 cells"Drug Metabol. Pharmacokin.. 17. 42-46 (2002)
M.Ogino:“曲格列酮在 HepG2 细胞中选择性抑制人 CYP3A 形式、CYP3A5 和 CYP3A7”药物代谢。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 9 条
CYP3A4 induction-associated dyslipidemia : a new risk factor for lifestyle disease
-
批准号:22659028
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$1.96万
-
财政年份:2010
-
负责人:YAMAZOE Yasushi
-
依托单位:
Regulation of hepatic lipid metabolism through ileal bile acid-FGF signaling
-
批准号:21390039
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.56万
-
财政年份:2009
-
负责人:YAMAZOE Yasushi
-
依托单位:
Mechanisms for delayed organ toxicity induced by drug and prediction system using comprehensive analysis
-
批准号:19390037
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.56万
-
财政年份:2007
-
负责人:YAMAZOE Yasushi
-
依托单位:
Mechanism for human-specific hepatotoxicity and development of prediction system
-
批准号:17390039
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.66万
-
财政年份:2005
-
负责人:YAMAZOE Yasushi
-
依托单位:
Bile acids, key compounds for the mechanistic analyses of hepatotoxicity, and nuclear receptor interaction
-
批准号:15390043
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.79万
-
财政年份:2003
-
负责人:YAMAZOE Yasushi
-
依托单位:
Grapefruit juice-drug interaction and the prediction
-
批准号:12557225
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.45万
-
财政年份:2000
-
负责人:YAMAZOE Yasushi
-
依托单位:
Role of intestinal oxidative metabolism on first pass effect
-
批准号:09470496
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$4.93万
-
财政年份:1997
-
负责人:YAMAZOE Yasushi
-
依托单位:
Development of as table expression system for human drug metabolizing enzymes
-
批准号:07557149
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$7.62万
-
财政年份:1995
-
负责人:YAMAZOE Yasushi
-
依托单位:
Analysis of mechanism of neonatal imprinting of drug-metabolizing enzymes of rat liver
-
批准号:60480130
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$4.22万
-
财政年份:1985
-
负责人:YAMAZOE Yasushi
-
依托单位:
海外基金